WallStreetZenWallStreetZen

NASDAQ: JAZZ
Jazz Pharmaceuticals PLC Stock Forecast, Predictions & Price Target

Analyst price target for JAZZ

Based on 11 analysts offering 12 month price targets for Jazz Pharmaceuticals PLC.
Min Forecast
$131.00+8.7%
Avg Forecast
$193.09+60.23%
Max Forecast
$230.00+90.86%

Should I buy or sell JAZZ stock?

Based on 11 analysts offering ratings for Jazz Pharmaceuticals PLC.
Strong Buy
Strong Buy
6 analysts 54.55%
Buy
4 analysts 36.36%
Hold
1 analysts 9.09%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their JAZZ stock forecasts and price targets.

JAZZ stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-22
lockedlocked$00.00+00.00%2024-03-22
lockedlocked$00.00+00.00%2024-03-20
lockedlocked$00.00+00.00%2024-03-20Find Out Why
lockedlocked$00.00+00.00%2024-03-20
Stifel Nicolaus
Top 4%
97
Strong BuyMaintains$230.00+90.86%2024-03-15Find out why
HC Wainwright & Co.
Bottom 10%
10
BuyMaintains$200.00+65.96%2024-03-14
UBS
Top 24%
77
HoldMaintains$131.00+8.70%2024-03-01
Barclays
Bottom 9%
9
Strong BuyMaintains$230.00+90.86%2024-03-01
RBC Capital
Top 3%
98
BuyReiterates$195.00+61.81%2024-02-29

1 of 2

Forecast return on equity

Is JAZZ forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.5%

Forecast return on assets

Is JAZZ forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

JAZZ revenue forecast

What is JAZZ's revenue in the next 3 years based on estimates from 10 analysts?
Avg 1 year Forecast
$4.1B+6.31%
Avg 2 year Forecast
$4.4B+15.09%
Avg 3 year Forecast
$4.6B+19.93%
JAZZ's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

JAZZ earnings growth forecast

How is JAZZ forecast to perform vs Biotechnology companies and vs the US market?
Company
64.32%
Industry
7.2%
Market
22.04%
JAZZ's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
JAZZ's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
JAZZ's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

JAZZ revenue growth forecast

How is JAZZ forecast to perform vs Biotechnology companies and vs the US market?
Company
6.48%
Industry
38.94%
Market
10.52%
JAZZ's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
JAZZ's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

JAZZ vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
JAZZ$120.51$193.09+60.23%Strong Buy
PCVX$68.50$96.00+40.15%Strong Buy
CYTK$71.41$84.39+18.17%Strong Buy
CERE$42.38$44.13+4.12%Hold
EXEL$23.86$27.57+15.55%Strong Buy

Jazz Pharmaceuticals Stock Forecast FAQ

Is Jazz Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 11 Wall Street analysts covering (NASDAQ: JAZZ) stock is to Strong Buy JAZZ stock.

Out of 11 analysts, 6 (54.55%) are recommending JAZZ as a Strong Buy, 4 (36.36%) are recommending JAZZ as a Buy, 1 (9.09%) are recommending JAZZ as a Hold, 0 (0%) are recommending JAZZ as a Sell, and 0 (0%) are recommending JAZZ as a Strong Sell.

If you're new to stock investing, here's how to buy Jazz Pharmaceuticals stock.

What is JAZZ's revenue growth forecast for 2024-2026?

(NASDAQ: JAZZ) Jazz Pharmaceuticals's forecast annual revenue growth rate of 6.48% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Jazz Pharmaceuticals's revenue in 2024 is $3,834,204,000.On average, 10 Wall Street analysts forecast JAZZ's revenue for 2024 to be $254,128,164,193, with the lowest JAZZ revenue forecast at $249,574,402,377, and the highest JAZZ revenue forecast at $257,183,644,167. On average, 10 Wall Street analysts forecast JAZZ's revenue for 2025 to be $275,118,200,002, with the lowest JAZZ revenue forecast at $258,770,331,620, and the highest JAZZ revenue forecast at $289,236,601,063.

In 2026, JAZZ is forecast to generate $286,684,808,630 in revenue, with the lowest revenue forecast at $258,025,928,941 and the highest revenue forecast at $316,572,513,848.

What is JAZZ's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: JAZZ) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is JAZZ's Price Target?

According to 11 Wall Street analysts that have issued a 1 year JAZZ price target, the average JAZZ price target is $193.09, with the highest JAZZ stock price forecast at $230.00 and the lowest JAZZ stock price forecast at $131.00.

On average, Wall Street analysts predict that Jazz Pharmaceuticals's share price could reach $193.09 by Mar 22, 2025. The average Jazz Pharmaceuticals stock price prediction forecasts a potential upside of 60.23% from the current JAZZ share price of $120.51.

What is JAZZ's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: JAZZ) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.